ACR Manual on MR Safety 2026: MRI Contrast Screening & Site Readiness

Key Takeaways

• The ACR Manual on MR Safety 2026, updated in March 2026, builds on the 2024 edition with clearer zone control, personnel, and radiofrequency safety recommendations.
• A new MR Pre-Appointment Guide appendix helps facilities screen patients earlier and reduce day-of cancellations tied to implants, devices, or renal risk.
• Contrast screening now centers on renal risk factors and lower-risk group II gadolinium agents, with routine eGFR testing often optional at standard doses.
• Site readiness means correct four-zone control, trained Level 2 personnel, emergency preparedness, and CMS-compliant supervision for every contrast exam.
• At ContrastConnect, we provide virtual contrast supervision that keeps sites covered and audit-ready.

Inside the ACR Manual on MR Safety 2026

The ACR first published its MR safe-practice guidance in 2002, and the manual is now the field's working reference. The 2024 edition has roughly 146 pages across 16 chapters and 5 appendices, and the 2026 update refines that text rather than replacing it. It is written for MR practitioners, technologists, medical physicists, administrators, and other staff who share responsibility for safety.

The document organizes safety around a four-zone facility model, defined personnel roles, screening duties, and equipment standards, based on consensus expert opinion and published evidence. Recent editions added key-point summary boxes, checklists, figures, and tables to make dense material easier to teach and apply. 

The manual also defines two tiers of MR Personnel, Level 1 and Level 2, with different training expectations for each, and sites are expected to update their local procedures whenever the manual changes.

ContrastConnect: Virtual Contrast Supervision That Never Misses

Built by Radiologists | 75,000+ Hours Monthly Contrast Exams | Trusted Nationwide

Built for Imaging Networks:

• Virtual Contrast Supervision: Radiologists provide immediate CMS-compliant supervision through a secure, HIPAA-compliant platform for outpatient facilities and hospital networks.
• Unmatched Experience: 130+ contrast reactions treated monthly with 3,900+ technologists certified.

The ContrastConnect Difference:

• ✓ Radiologist-owned with superior clinical expertise
• ✓ Always-on platform with guaranteed compliance
• ✓ Audit-ready documentation for CMS reviews
• ✓ Cost-efficient alternative to onsite staffing

Safety & Compliance You Trust:

Helping imaging centers reduce cancellations, extend hours, and scale operations without adding on-site radiologists. Response times measured in seconds.

Start Your Coverage Assessment →

MRI Contrast Screening Under Current Guidance

Contrast screening is the process a facility follows before giving a patient a gadolinium-based contrast agent (GBCA). The goal is to identify patients who face a higher risk of harm from the agent itself, whether that risk is renal or allergic.

The main concern behind renal screening is nephrogenic systemic fibrosis (NSF), a rare but serious condition tied to gadolinium exposure in patients with severe kidney impairment. The FDA also reports that small amounts of gadolinium can stay in the body for months to years after a scan, which is why agent selection and dosing still matter even as newer agents have lowered the overall risk.

Current guidance breaks screening into two areas: renal function, which determines whether contrast is safe to give and which agent to use, and reaction history, which determines whether the patient needs extra precautions before the exam. Both feed into the same safety form and are covered below.

Renal Function & Gadolinium Agents

Current screening focuses on renal risk. Group II GBCAs, such as gadoteridol, gadoterate, and gadobutrol, carry little to no measured NSF risk. A pooled analysis cited in a cardiology imaging review found an NSF risk of roughly 0 to 0.07 percent in patients with an eGFR under 30 who received a group II agent. On that evidence, the 2021 ACR and National Kidney Foundation consensus made kidney-function screening optional at standard doses of these agents.

Facilities still evaluate eGFR when risk factors are present, and many keep extra caution for dialysis patients or those with acute kidney injury. The result is targeted screening based on patient history and risk factors, rather than universal lab testing before every study. When repeat contrast studies are needed, spacing them out remains standard practice.

Reactions & Pre-Exam Screening

Screening also records allergic-type reactions, prior contrast reactions, asthma, and pregnancy or breastfeeding status. For gadolinium, the standard approach is to give contrast only when the benefit clearly outweighs the possible risk. Staff reviews these factors on a standardized safety form, and the new pre-appointment appendix moves much of that review earlier in the process. 

When a reaction occurs, a supervising physician must be on hand to direct treatment, which links contrast screening to site readiness. For patients with a known contrast allergy, some sites use a premedication protocol, though the supporting evidence for gadolinium is extrapolated from iodinated contrast rather than established on its own.

MRI Site Readiness Requirements

Site readiness means the building, the staff, the equipment, and the supervision are all in place before the first contrast scan of the day. A gap in any one of these can stop a scanner or put a patient at risk.

Zones, Personnel, & Equipment

The four-zone model runs from the public entry at Zone I to the magnet room at Zone IV, with Zone III as the controlled interface and the 9-gauss line marking the magnetic hazard area. Zone I is freely accessible, and Zone II is where patients are greeted and screened before they move into the more strictly controlled areas. 

The manual calls for at least one trained Level 2 MR technologist per scanner during routine hours, plus one additional MR person in Zone III. Readiness also requires working emergency call systems, monitored equipment inside Zone IV, ferromagnetic detection at the entry, and a stocked crash cart with staff trained to manage reactions.

Supervision & CMS Compliance

Every contrast exam needs a supervising physician who is immediately available. As of January 1, 2026, CMS permanently allows that supervision to be delivered virtually through real-time, two-way audio and video technology for diagnostic tests, including contrast CT and MRI, across office and hospital outpatient settings.

The 2026 Physician Fee Schedule final rule confirms that audio-only contact does not qualify, and the connection must stay live for the full exam. Facilities must document who supervised, their credentials, the technology used, and that the connection held throughout. State law can add requirements, so multi-site groups must confirm the rules in each location.

Meeting 2026 MR Safety Standards With ContrastConnect

The 2026 updates bring screening, zoning, personnel, and supervision under one consistent framework, and staying compliant means every piece has to hold for every contrast exam. ContrastConnect was built to cover the supervision piece, providing always-on virtual contrast supervision from radiologists through a secure, HIPAA-compliant platform with response times measured in seconds and audit-ready documentation for CMS reviews.

Whether your network is adding locations, extending scanner hours, or filling gaps left by staffing shortages, ContrastConnect keeps sites covered without adding on-site radiologists. To see how remote supervision would fit your sites, start a coverage assessment with our team.

Frequently Asked Questions (FAQs)

Is virtual contrast supervision permitted in every state?

CMS permits virtual direct supervision nationwide as of January 2026, but states can impose stricter rules, and some require the supervising physician to hold a license in the patient's state. A few states allow exemptions where virtual coverage is otherwise limited. Confirm current licensure and supervision rules in each state before you deploy remote coverage.

Who is responsible for MR safety at an imaging facility?

The ACR model assigns oversight to an MR Medical Director, supported by an MR Safety Officer and, at larger sites, an MR Safety Expert. Day-to-day, trained Level 2 personnel control the scanner area and screening, while all staff follow the facility's written safety program. These roles set policy, training, and incident response.

Can patients get a contrast MRI while pregnant or breastfeeding?

Gadolinium is generally given during pregnancy only when the benefit clearly outweighs the risk, since it crosses the placenta. For breastfeeding, current guidance treats it as safe to continue nursing after a group II agent, because very little passes into breast milk. The referring physician and radiologist weigh each case individually.

Do MRI safety requirements apply to scans without contrast?

Yes. The four-zone layout, ferromagnetic screening, trained Level 2 personnel, and emergency readiness apply to every MRI, because the magnetic field and projectile risk exist with or without contrast. Contrast adds a further step: renal and allergy screening, plus physician supervision during contrast administration.

How does ContrastConnect keep supervision reliable?

We provide always-on virtual contrast supervision from specialized radiologists on a secure, HIPAA-compliant platform, with response times measured in seconds and redundant backup coverage. Our team supervises a large monthly volume of contrast exams and maintains audit-ready documentation, so sites stay covered and compliant during staffing shortages.

‍

Note: Information provided is for general guidance only and does not constitute medical, legal, or financial advice. Pricing estimates and regulatory requirements are current at the time of writing and subject to change. For personalized consultation on imaging center operations and virtual contrast supervision, contact ContrastConnect.